• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉扩张症:非动脉粥样硬化性分子和病理生理概念综述。

Coronary Artery Ectasia: Review of the Non-Atherosclerotic Molecular and Pathophysiologic Concepts.

机构信息

Cardiovascular Research Institute (CVRI) Dublin, Mater Private Hospital, D07 WKW8 Dublin, Ireland.

School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.

出版信息

Int J Mol Sci. 2022 May 6;23(9):5195. doi: 10.3390/ijms23095195.

DOI:10.3390/ijms23095195
PMID:35563583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9103542/
Abstract

Coronary artery ectasia (CAE) is frequently encountered in clinical practice, conjointly with atherosclerotic CAD (CAD). Given the overlapping cardiovascular risk factors for patients with concomitant CAE and atherosclerotic CAD, a common underlying pathophysiology is often postulated. However, coronary artery ectasia may arise independently, as isolated (pure) CAE, thereby raising suspicions of an alternative mechanism. Herein, we review the existing evidence for the pathophysiology of CAE in order to help direct management strategies towards enhanced detection and treatment.

摘要

冠状动脉扩张症(CAE)在临床实践中经常遇到,同时伴有动脉粥样硬化性 CAD(CAD)。鉴于同时患有 CAE 和动脉粥样硬化性 CAD 的患者存在重叠的心血管危险因素,通常假设存在共同的潜在病理生理学机制。然而,冠状动脉扩张症也可能独立发生,即单纯性 CAE,从而引起对替代机制的怀疑。在此,我们回顾了 CAE 病理生理学的现有证据,以帮助指导管理策略,从而加强对其的检测和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27d0/9103542/d8525ae6279f/ijms-23-05195-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27d0/9103542/93c0a50116ba/ijms-23-05195-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27d0/9103542/d8525ae6279f/ijms-23-05195-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27d0/9103542/93c0a50116ba/ijms-23-05195-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27d0/9103542/d8525ae6279f/ijms-23-05195-g002.jpg

相似文献

1
Coronary Artery Ectasia: Review of the Non-Atherosclerotic Molecular and Pathophysiologic Concepts.冠状动脉扩张症:非动脉粥样硬化性分子和病理生理概念综述。
Int J Mol Sci. 2022 May 6;23(9):5195. doi: 10.3390/ijms23095195.
2
Prevalence and Angiographic Characteristics of Coronary Artery Ectasia among Patients with Coronary Artery Disease: A Retrospective Analysis between 2014 and 2022.冠状动脉疾病患者中冠状动脉扩张的患病率和血管造影特征:2014 年至 2022 年的回顾性分析。
Tohoku J Exp Med. 2023 Oct 24;261(2):165-171. doi: 10.1620/tjem.2023.J065. Epub 2023 Aug 10.
3
Novel insights into an old controversy: is coronary artery ectasia a variant of coronary atherosclerosis?对一个古老争议的新见解:冠状动脉扩张是冠状动脉粥样硬化的一种变体吗?
Clin Res Cardiol. 2007 Jun;96(6):331-9. doi: 10.1007/s00392-007-0521-0. Epub 2007 Apr 26.
4
The Impact of C-Peptide and Diabetes Mellitus on Coronary Ectasia and Effect of Coronary Ectasia and C-Peptide on Long-Term Outcomes: A Retrospective Cohort Study.C-肽和糖尿病对冠状动脉扩张的影响及冠状动脉扩张和 C-肽对长期预后的影响:一项回顾性队列研究。
Int J Clin Pract. 2022 Oct 8;2022:7910566. doi: 10.1155/2022/7910566. eCollection 2022.
5
[Coronary artery ectasia: clinical and angiographical evaluation].[冠状动脉扩张:临床与血管造影评估]
Turk Kardiyol Dern Ars. 2008 Dec;36(8):530-5.
6
Coronary Artery Aneurysm Differs From Coronary Artery Ectasia: Angiographic Characteristics and Cardiovascular Risk Factor Analysis in Patients Referred for Coronary Angiography.冠状动脉瘤与冠状动脉扩张的差异:接受冠状动脉造影患者的血管造影特征及心血管危险因素分析
Angiology. 2017 Oct;68(9):823-830. doi: 10.1177/0003319716665690. Epub 2016 Aug 27.
7
Coronary Artery Ectasia: Clinical and Angiographic Features.冠状动脉扩张:临床及血管造影特征
J Coll Physicians Surg Pak. 2018 Nov;28(11):824-828. doi: 10.29271/jcpsp.2018.11.824.
8
Coronary Artery Ectasia in the Pathophysiology of Myocardial Infarction With Nonobstructive Coronary Arteries.冠状动脉扩张在非阻塞性冠状动脉心肌梗死的病理生理学中的作用。
Am J Cardiol. 2022 May 15;171:28-31. doi: 10.1016/j.amjcard.2022.01.043. Epub 2022 Mar 11.
9
Prognostic Value of Coronary Artery Stenoses, Markis Class, and Ectasia Ratio in Patients with Coronary Artery Ectasia.冠状动脉扩张患者中冠状动脉狭窄、Markis分级及扩张率的预后价值
Cardiology. 2015;131(4):251-9. doi: 10.1159/000381702. Epub 2015 May 12.
10
Association of Epicardial Fat Volume with Coronary Artery Ectasia and Coronary Artery Disease.心外膜脂肪体积与冠状动脉扩张和冠状动脉疾病的关系。
Angiology. 2023 Jul;74(6):563-568. doi: 10.1177/00033197221124776. Epub 2022 Aug 30.

引用本文的文献

1
Electrocardiographic markers of arrhythmogenic risk in patients with isolated coronary artery ectasia.孤立性冠状动脉扩张患者心律失常风险的心电图标志物
Int J Cardiol Cardiovasc Risk Prev. 2025 Aug 13;27:200492. doi: 10.1016/j.ijcrp.2025.200492. eCollection 2025 Dec.
2
Paraoxonase 1 Enzyme Activity in Patients With Isolated Coronary Artery Ectasia.孤立性冠状动脉扩张患者的对氧磷酶1酶活性
Cureus. 2025 May 8;17(5):e83703. doi: 10.7759/cureus.83703. eCollection 2025 May.
3
C-Reactive Protein, Uric Acid, and Coronary Artery Ectasia in Patients with Coronary Artery Disease.

本文引用的文献

1
Differential Expression of Circulating Damage-Associated Molecular Patterns in Patients with Coronary Artery Ectasia.冠状动脉扩张患者循环损伤相关分子模式的差异表达
Biomolecules. 2023 Dec 21;14(1):10. doi: 10.3390/biom14010010.
2
Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis.冠状动脉扩张中的炎症生物标志物:系统评价与荟萃分析
Diagnostics (Basel). 2022 Apr 19;12(5):1026. doi: 10.3390/diagnostics12051026.
3
Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
冠心病患者的C反应蛋白、尿酸与冠状动脉扩张
Med Sci Monit. 2025 Jan 27;31:e947158. doi: 10.12659/MSM.947158.
4
Antithrombotic therapy in adults with ectatic coronary artery disease: a systematic review and network meta-analysis.成人扩张型冠状动脉疾病的抗栓治疗:一项系统评价和网状Meta分析。
Egypt Heart J. 2025 Jan 22;77(1):13. doi: 10.1186/s43044-025-00612-8.
5
Mitochondrial calcium uniporter complex: An emerging therapeutic target for cardiovascular diseases (Review).线粒体钙单向转运体复合物:心血管疾病中一个新出现的治疗靶点(综述)
Int J Mol Med. 2025 Mar;55(3). doi: 10.3892/ijmm.2024.5481. Epub 2025 Jan 3.
6
New Insights into the Pathophysiology of Coronary Artery Aneurysms.冠状动脉瘤病理生理学的新见解
Diagnostics (Basel). 2024 Sep 29;14(19):2167. doi: 10.3390/diagnostics14192167.
7
[MINOCA and Coronary Ectasia: a rare combination of causes of infarction].[心肌梗死伴非阻塞性冠状动脉粥样硬化和冠状动脉扩张:一种罕见的梗死病因组合]
Rev Fac Cien Med Univ Nac Cordoba. 2024 Mar 27;81(1):155-166. doi: 10.31053/1853.0605.v81.n1.43231.
8
Advances in the study of S100A9 in cardiovascular diseases.S100A9 在心血管疾病中的研究进展。
Cell Prolif. 2024 Aug;57(8):e13636. doi: 10.1111/cpr.13636. Epub 2024 Mar 19.
9
Atherosclerotic and Cardio-Metabolic Diseases: From Molecular Basis to Therapeutic Advances.动脉粥样硬化和心血管代谢疾病:从分子基础到治疗进展。
Int J Mol Sci. 2023 Jun 4;24(11):9737. doi: 10.3390/ijms24119737.
肠道微生物群依赖性代谢产物氧化三甲胺(TMAO)与疑似功能性相关冠状动脉疾病(fCAD)患者的心血管风险
Clin Res Cardiol. 2022 Jun;111(6):692-704. doi: 10.1007/s00392-022-01992-6. Epub 2022 Feb 26.
4
Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias.冠状动脉扩张患者脂肪酸的代谢组学特征
Front Physiol. 2021 Nov 19;12:770223. doi: 10.3389/fphys.2021.770223. eCollection 2021.
5
Pharmacologic Management of Coronary Artery Ectasia.冠状动脉扩张症的药物治疗
Cureus. 2021 Sep 8;13(9):e17832. doi: 10.7759/cureus.17832. eCollection 2021 Sep.
6
Correlation between aortic root dimension and coronary ectasia.主动脉根部尺寸与冠状动脉扩张的相关性。
Coron Artery Dis. 2021 Jun 1;32(4):335-339. doi: 10.1097/MCA.0000000000000977.
7
Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome.单核细胞趋化蛋白-1是急性冠状动脉综合征患者冠状动脉扩张的独立预测因子。
J Clin Med. 2020 Sep 21;9(9):3037. doi: 10.3390/jcm9093037.
8
Anti-inflammatory effects of rosuvastatin treatment on coronary artery ectasia patients of different age groups.瑞舒伐他汀治疗对不同年龄组冠状动脉瘤患者的抗炎作用。
BMC Cardiovasc Disord. 2020 Jul 11;20(1):330. doi: 10.1186/s12872-020-01604-z.
9
Assessment of the Relationship Between C-Reactive Protein-to-Albumin Ratio and the Presence and Severity of Isolated Coronary Artery Ectasia.评估 C 反应蛋白与白蛋白比值与孤立性冠状动脉瘤扩张的存在及严重程度的关系。
Angiology. 2020 Oct;71(9):840-846. doi: 10.1177/0003319720930983. Epub 2020 Jun 10.
10
Diffuse coronary artery dilation predicted worse long-term outcomes in patients with coronary artery Ectasia.弥漫性冠状动脉扩张预示着冠状动脉扩张症患者的长期预后更差。
Int J Cardiol. 2020 Nov 15;319:20-25. doi: 10.1016/j.ijcard.2020.05.054. Epub 2020 Jun 3.